Bringing you live news and features since 2006 

HANetf’s Medicinal Cannabis Fund (CBDX) passported for distribution in the Netherlands and Finland


HANetf, Europe’s first ‘white label’ ETF issuer, has registered its landmark medical cannabis ETF for sale in the Netherlands and Finland. CBDX – The Medical Cannabis and Wellness UCITS ETF – was launched in January 2020 on XETRA and the London Stock Exchange with Purpose Investments as sponsor.

CBDX provides investors with the opportunity to gain exposure to a basket of carefully vetted companies that have high exposure to the medicinal cannabis, hemp and cannabinoids (CBD) industry. It is the only UCITS ETF which is providing this level of targeted exposure.

The fund tracks a rules-based Medical Cannabis and Wellness Equity Index from Solactive, consisting of publicly listed companies conducting legal business activities in the medical cannabis, hemp and CBD industries. The methodology uses a rigorous and multi-tiered screening process to identify and exclude companies that are involved in the adult-use Cannabis market.

CBDX is constantly monitored to ensure that it remains focused exclusively on stocks that are dedicated to the medical cannabis market. Companies that have retail cannabis exposure are screened out.

The sponsor of CBDX is Purpose Investments of Canada. Purpose is a highly innovative fund management business with over USD8 billion in assets under management (as of January 2020). In 2017, Purpose Investments launched a cannabis fund in Canada (the Purpose Marijuana Opportunities Fund), and have a deep understanding of this exciting, high growth industry sector.

Nawan Butt, Portfolio Manager at Purpose Investments, says: “The launch of CBDX in the UK and Germany comes at a time when the sell-off in cannabis stocks has created new value and a new entry point for investors interested in this sector. Medicinal stocks in this sector are again showing value against long term growth targets. We expect to see further deregulation of medical cannabis products and additional take up within the healthcare sector in the near future, which will drive prices.”

Ignatius Faisal, Director of Product Management at HANetf, adds:
“While the North American ETF market is well-served with products that track cannabis indexes, this is the first and currently only UCITS ETF authorised for distribution in the European market. With the addition of the Netherlands and Finland as markets for distribution, more investors will be able to access the fast-developing medical cannabis story.”

Latest News

News came last night from the US that the SEC has approved CBOE’s proposal to list and trade VanEck’s spot..
Irish domiciled funds surpassed EUR4.3 trillion AuM (Assets under Management) at end-March 2024, a 15 per cent increase in net..
European white label ETF platform, HANetf, has announced its total assets under management (AUM) has now exceeded USD4.31 billion...
New research from European ETF provider Tabula Investment Management shows investors are expecting improvements in ESG from the gold mining..

Related Articles

Timothy Rotolo, Range Funds
In 2023, Timothy Rotolo launched his business, Range Fund Holdings, the parent company for Range Indices and Range ETFs, followed...
Dan Miller, IQ-EQ
With just over a week to go till T+1 settlement begins in North America, Canada and Mexico, time is of...
Emily Spurling, Nasdaq
Last October’s ETF Express US Awards 2023 found Nasdaq winning Best Index Provider – ESG ETFs and Best Index Provider...
Vinit Srivistava, MerQube
Index provider, MerQube, launched in 2019, with the aim of providing a “technology-driven answer to the most complex, rules-based investment...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by